Clinical Trial Results:
A multicenter, double-blind, randomized, placebo-controlled, parallel group, event-driven, Phase III study to assess the effects of ACT-064992 on morbidity and mortality in patients with symptomatic pulmonary arterial hypertension
Summary
|
|
EudraCT number |
2007-002440-14 |
Trial protocol |
GB BE DE NL FR FI SE AT DK SK PT IT BG |
Global completion date |
15 Mar 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Jul 2016
|
First version publication date |
16 Aug 2015
|
Other versions |
|
Summary report(s) |
AC-055 302_eu results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.